麻豆社

Anthony Harnden the new chair of the Medicine and Healthcare products Regulatory Agency.

Following the announcement, Richard Torbet, Chief Executive of the Association of the British Pharmaceutical Industry (ABPI), said:

鈥淚 would like to offer my warm congratulations to Professor Harnden on his appointment as Chair of the MHRA. His significant experience and expertise within the health ecosystem, especially his time at the JCVI during the COVID-19 pandemic, provide a strong foundation on which to build his leadership of the MHRA.

鈥淧rofessor Harnden鈥檚 appointment comes at a pivotal time for the agency as it works to rebuild and strengthen its role as a global leader in medicines regulation. Our industry stands ready to support him and the wider MHRA in continuing to deliver the highest UK quality and safety standards alongside timely patient access to new medicines and technologies.鈥�

The 麻豆社will shortly publish a new report with a number of recommendations designed to help rebuild the UK鈥檚 world-class reputation in regulatory science, medicines development and licensing.